U.S. Government, Pharmaceutical Companies Working Quickly To Develop COVID-19 Vaccines, Treatments For Testing

Devex: Inside the race to find a coronavirus vaccine
“The global health community is trying to fast-track the development of a vaccine against the novel coronavirus. COVID-19 has now affected over 70 countries globally, with 93,090 confirmed cases and 3,198 deaths. Questions are also emerging on global access to the vaccine, once a viable candidate has been developed…” (Ravelo, 3/5).

Financial Times: U.S. defense department in race to identify coronavirus treatment
“Scientists funded by the U.S. defense department are racing to extract coronavirus antibodies from the blood of a recovered patient, in an attempt to develop short-term treatments to protect frontline healthcare workers and military personnel…” (Manson, 3/4).

Washington Post: Fact-checking Trump’s accelerated timeline for a coronavirus vaccine
“…Health experts say they have completed vaccine options ready for testing at a historically fast rate. However, a vaccine available for public use is different than a vaccine ready for the first phase of testing. Experts have emphasized that actual deployment of the vaccine is more than a year away, not a few months, as Trump has suggested…” (Samuels, 3/4).

Additional coverage of efforts to develop a COVID-19 vaccine is available from Financial Times, IBT, and STAT.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.